Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
T-Biyoteknoloji is a Turkish biotechnology company specializing in the development and manufacture of regenerative medicine products and medical devices. The company is best known for its T-LAB brand, which offers a comprehensive range of kits for Platelet-Rich Plasma (PRP), Stromal Vascular Fraction (SVF), and Bone Marrow Aspirate Concentrate (BMAC) preparation. These autologous cell therapy solutions are designed for point-of-care use in various clinical fields, including orthopedics, dermatology, and plastic surgery. T-Biyoteknoloji maintains rigorous quality standards, operating with ISO 13485 certification and CE marking for its medical devices. Their products facilitate the concentration of growth factors and stem cells to promote tissue repair and regeneration. The company serves a global market, providing clinicians with standardized protocols for regenerative treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on T-Biyoteknoloji.